Patient Square Capital completed a $125m investment in Eargo.

Patient Square Capital, a health care investment firm, completed a $125m investment in Eargo, a medical device company. “We believe this commitment of up to $125m in additional capital from an experienced healthcare investor will enable us to pursue our omni-channel growth strategy powered by telecare. This includes further optimizing our cash-pay business, focusing on potentially regaining insurance coverage of Eargo for government employees under the FEHB program, and refining and expanding our physical retail strategy,” Christian Gormsen, Eargo President and CEO.